NovaBridge Biosciences (NBP) Depreciation and Depletion (2019 - 2025)
NovaBridge Biosciences (NBP) reported Depreciation and Depletion of $15000.0 for Q4 2025, down 31.82% year-over-year from $22000.0 in Q4 2024, and down 11.76% on a QoQ basis from $17000.0 in Q3 2025.
NovaBridge Biosciences (NBP) has 4 years of Depreciation and Depletion data on file, last reported at $15000.0 in Q4 2025.
- Quarterly Depreciation and Depletion fell 31.82% year-over-year to $15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $74000.0 (down 93.95% YoY) and the FY2025 annual result came in at $68000.0, down 73.95% from the prior year.
- Depreciation and Depletion fell to $15000.0 in Q4 2025 per NBP's latest filing, from $17000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $22000.0 in Q4 2024 and bottomed at $15000.0 in Q4 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Dec 31, 2025 | 15,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Dec 31, 2020 | 755,220.95 |
| Dec 31, 2020 | 755,220.95 |
| Dec 31, 2019 | 425,074.79 |
| Dec 31, 2019 | 425,074.79 |